Contamination of Tissue Cultures by Mycoplasmas by Rottem, Shlomo et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books










© 2012 Rottem et al., licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Contamination of Tissue Cultures  
by Mycoplasmas 
Shlomo Rottem, Nechama S. Kosower and Jonathan D. Kornspan 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/51518 
1. Introduction 
Mycoplasmas are the smallest and simplest self-replicating bacteria [1]. These 
microorganisms lack a peptidoglycan based rigid cell wall and thus are not susceptible to 
antibiotics, such as penicillin and its analogues, which are effective against most bacterial 
contaminants of cell cultures. The trivial name mycoplasma encompasses all species 
included in the class Mollicutes: i.e. the genera Mycoplasma, Acholeplasma, Spiroplasma, 
Anaeroplasma and Ureaplasma. Because mycoplasmas have an extremely small genome (0.58–
2.20 Mb compared with the 4.64 Mb of Escherichia coli), these organisms have limited 
metabolic options for replication and survival. The smallest genome of a self-replicating 
organism known at present is the genome of Mycoplasma genitalium (0.58 Mb; Ref. 2). 
Comparative genomic studies suggested that the genome of this organism still carries 
almost double the number of genes included in the minimal gene set essential for cellular 
function [3]. Owing to their limited biosynthetic capabilities, most mycoplasmas are 
parasites, exhibiting strict host and tissue specificities [4]. The aim of this review is to collate 
present knowledge on the strategies employed by mycoplasmas while interacting with 
tissue culture cells. Prominent among these strategies is the adherence of mycoplasmas to 
host cells, the invasion of mycoplasmas into host cells and the fusion of mycoplasmas with 
host cells. We shall discuss the intriguing questions of how a mycoplasma infecting tissue 
culture cells subvert and damage the host cells by mediating transformation of the cells, 
affecting the signal-transduction pathways and the metabolism of immune and non-
immune cells. We shall also present and discuss the common procedures for isolation, 
identification and eradication of a mycoplasma contamination of tissue cultures. 
2. Mycoplasmas contaminating cultured cells  
It is well established that stable cell cultures are frequently contaminated by mycoplasmas. 
In a study carried out in the USA at the Food and Drug Administration (FDA), over 20,000 
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cell cultures were examined during a period of 30 years, 15% of which were found to be 
contaminated [5]. Higher incidences of contamination have also been reported. Three 
different surveys in Japan showed an incidence of mycoplasma contamination of 60-80%, 
and an incidence of 65% was reported in Argentina [5]. At least 20 distinct Mycoplasma or 
Acholeplasma species have been isolated from contaminated cell lines. Ninety-five percent of 
the contaminants were identified as either M. orale, M. arginini, M. hyorinis, M. fermentans or 
A. laidlawii [5]. although the frequency of isolation of a particular species varies with the 
particular study. 
In general, primary cell cultures are less frequently contaminated than continuous cell lines. 
However, since many viral vaccines (such as those for measles, mumps, rubella, polio and 
rabies) are produced in primary cell cultures, many countries require such cultures to be 
screened carefully for mycoplasma contamination before approval can be given for release 
of the vaccine (or other biological products intended for human use) to the market-place.  
All cell types, including virus-infected, transformed, or neoplastic cell cultures grown in 
monolayers and/or in suspension, derived from all host-types examined, are subject to 
contamination. Mammalian and avian cell lines were the most commonly contaminated 
although, on occasions, cell cultures derived from reptiles, fish, insects or plants were also 
contaminated. Most studies have examined fibroblast cell cultures, but epithelial, 
endothelial, lymphocytic and hybridoma cell-culture lines have also been found to be 
contaminated. Frequently, the number of mycoplasmas far exceeds (often by 1000-fold) the 
number of tissue-culture cells in an infected cell culture. The information available on the 
contamination of cultures of differentiated cell lines is limited, and more data are needed 
before a proper assessment can be made. Mycoplasma contamination of vaccines presents a 
potential health hazard; consequently, identifying the source(s) of contamination is a key 
concern. The probable source of most mycoplasma contaminants in primary cell culture is 
the original tissue used to develop the primary cell culture lot. Whereas lung, kidney, or 
liver tend to be mycoplasma-free, the foreskin, the lower female-urogenital tract, or tumor 
tissues, are subject to mycoplasma colonization, and generally show a higher rate of 
contamination [5]. Nonetheless, contamination from exogenous sources also occurs during 
cell propagation and continuous cell cultures are the most frequently contaminated. The 
main source of contamination is, in many cases, infection by previously-contaminated cell 
cultures that have been maintained and processed in the same laboratory [5]. Mycoplasmas 
are spread by using laboratory equipment, media, or reagents that have been contaminated 
by previous use in processing mycoplasma-infected cell cultures. New cell-culture 
acquisitions should be quarantined, tested and guaranteed mycoplasma-free before 
introduction into the tissue-culture laboratory. Common experimental stock materials, such 
as virus pools, or monoclonal antibody preparations, can also be a key source of 
mycoplasma contamination. As there is no legal requirement for suppliers to provide 
mycoplasma-free products, bovine serum should be considered as a possible source of 
contamination. Mycoplasma contaminants of bovine serum are primarily bovine species, 
with A. laidlawii and M. arginini being isolated most frequently [5]. 
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3. Mode of interaction with host cells  
3.1. Adherence to host cells 
Most mycoplasmas are typical extracellular microorganisms able to adhere to the surface of 
tissue culture cells. Many mycoplasmas exhibit the typical polymorphism of mycoplasmas, 
with the most common filamentous, flask shapes or ovoid structures (Figure 1, Ref. 6). The 
adherence of mycoplasmas to host cells is an initial and essential step in tissue colonization 
[4]. The lack of a cell wall has forced mycoplasmas to develop sophisticated molecular 
mechanisms to enable their prolonged adhesion. Adherence is associated with adhesins as 
well as host cell receptors that mediate interaction of the bacteria with the host cells [7]. 
 
Figure 1. Transmission electron microscopy of M. hyorhinis (A) and of a melanoma cell culture infected 
by M. hyorhinis (B). Flask shaped bacteria in close proximity to melanoma cells are indicated by arrows. 
A polar, tapered cell extension at one of the poles containing an electron-dense core in the 
cytoplasma was described in some mycoplasmas (Figure 2). This structure, termed the tip 
organelle, functions mainly as an attachment and motility organelle. A variety of surface 
proteins that participate in the adhesion process are densely clustered at the tip organelle 
[4]. The role of host cell surface sialoglycoconjugates as receptors for mycoplasmas has been 
suggested [8]. The carbohydrate moiety of the glycoprotein, which serves as a receptor for 
M. pneumoniae on human erythrocytes, has been identified as having a terminal NeuAc(α2–
3)Gal(β1–4)GlcNAc sequence [9]. Nevertheless, neuraminidase treatment has frequently 
failed to abolish the ability of various eukaryotic cells to bind M. pneumoniae [10]. A sialic 
acid-free glycoprotein, isolated from cultured human lung fibroblasts, which serves as a 
receptor for M. pneumoniae, has been isolated by Geary et al. [11]. Sulfated glycolipids 
containing terminal Gal(3SO4)β1 residues were also found to function as receptors [12]. 
Clearly, there is more than one type of receptor for the various adhering mycoplasmas.  
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Figure 2. A, scanning electron microscopy of filamentous M. pneumoniae. B, transmission electron 
microscopy of flask-shaped M. pneumoniae (M) attached by the terminal tip organelle (arrow) to ciliated 
mucosal cells. Magnification: A, x10,000; B, x36,000. 
The attachment of mycoplasmas to the surface of host cells may interfere with membrane 
receptors or alter transport mechanisms of the host cell. The disruption of the K+ channels of 
ciliated bronchial epithelial cells by M. hyopneumoniae that resulted in ciliostasis has been 
described [13]. The host cell membrane is also vulnerable to toxic materials released by the 
adhering mycoplasmas. Although toxins have not been associated with mycoplasmas, the 
production of cytotoxic metabolites and the activity of cytolytic enzymes are well 
established. Oxidative damage to the host cell membrane by peroxide and superoxide 
radicals excreted by the adhering mycoplasmas appears to be experimentally well-
substantiated [14]. The intimate contact of the mycoplasma with the host cell membrane 
may also result in the hydrolysis of host cell phospholipids catalyzed by the potent 
membrane-bound phospholipases present in many mycoplasma species [15]. This could 
trigger specific signal cascades [16] or release cytolytic lysophospholipids capable of 
disrupting the integrity of the host cell membrane [17, 18].  
3.2. Invasion of host cells 
It is generally accepted that mycoplasmas remain attached to the surface of host cells [1]. 
However, some mycoplasmas have evolved mechanisms for entering host cells that are 
not naturally phagocytic. The intracellular location is obviously a privileged niche, well 
protected from the action of many antibiotics. Mycoplasma invasion of host cells was 
intensively studied with M. penetrans, isolated from the urogenital tract of acquired 
immunodeficiency syndrome (AIDS) patients [19, 20]. It was shown that this 
microorganism has invasive properties and localizes in the cytoplasm and perinuclear 
regions [21, 22, 23]. Mycoplasmal invasion of host cells is a complex process that involves 
a variety of mycoplasmal and host cell factors. It is likely that surface molecules (proteins 
and lipids) that facilitate the adhesion process of mycoplasmas will have an effect on the 
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invasion. Nevertheless, adherence to the surface of host cells is not sufficient to trigger 
events that lead to invasion. The signals generated by the interaction of host cells with 
invasive mycoplasmas have yet to be investigated. It has been shown that bacterial 
invasion is based on the ability of several bacteria to bind sulfated polysaccharides or 
fibronectin [24]. It was suggested that these compounds form a molecular bridge between 
the bacteria and eukaryotic surface proteins [25] that enables invasion. Fibronectin 
binding activity was detected in M. penetrans. This organism, which contains a 65-kDa 
fibronectin binding protein, binds selectively immobilized fibronectin [23]. The finding 
that M. fermentans binds plasminogen (Plg) and in the presence of urokinase-type Plg 
activated (uPA) internalization was apparent (26, 27), indicates that the ability of M. 
fermentans to invade host cell stems from its potential to bind and activate Plg to plasmin, 
a protease with broad substrate specificity. Plg and uPA are two proteins that play an 
important role in the invasion of several human malignant tumors [28], therefore it is not 
surprising that the same system stimulates M. fermentans invasion. Other mycoplasmas 
known to be surface parasites such as M. pneumoniae [29], M. genitalium [30], M. 
gallisepticum [31], and M. hyorhinis [6] were also found under certain circumstances to 
reside within host cells. 
In studying bacterial invasion, it is essential to differentiate between microorganisms 
adhering to a host cell and those which have penetrated the cell. The light microscopic and 
electron microscopic observations of mycoplasmas engulfed in membrane vesicles lead to 
conflicting interpretations. It is not clear whether mycoplasmas are intra, or are they at the 
bottom of crypts formed by the invagination of the cell membrane [32]. A more 
sophisticated ultrastructural study was based on a combined immunochemistry and 
electron microscopy approach. Staining surface polysaccharides of the host cell with 
ruthenium red allows a better differentiation between intracellular and extracellular 
mycoplasmas [33]. Currently, the gentamicin resistance assay is the most common assay to 
differentiate intracellular from extracellular bacteria [7, 34]. In this assay, the extracellular 
bacteria are killed by gentamicin, but the intracellular bacteria are shielded from the 
antibiotic because of the limited penetration of the gentamicin into eukaryotic cells. The 
gentamicin procedure was successfully adapted to mycoplasma systems [21, 31]. Usually the 
number of intracellular bacteria is determined by washing the host cells free of the 
antibiotic, lysing them with mild detergents to release the bacteria and counting the colonies 
[35]. Because mycoplasmas are as susceptible to detergent lysis as the host cells, dilutions of 
the mycoplasma-infected host cells should be plated directly onto solid mycoplasma media 
without lysing them beforehand. Each mycoplasma colony represents one infected host cell 
rather than a single intracellular mycoplasma [34].  
Immunofluorescent staining of internalized bacteria and of those remaining on the cell 
surface, combined with confocal laser scanning microscopy, has demonstrated that several 
mycoplasmas penetrate eukaryotic cells (Figure 3; Refs. 22, 36) This nondestructive, high-
resolution method allowed infected host cells to be optically sectioned after fixation and 
immunofluorescent labeling. Imaging single infected HeLa cells revealed that invasion is 
both time and temperature dependent. Penetration of melanoma cells by M. hyorhinis has 
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been observed as early as 30 min after infection [6], whereas invasion of cultured HEp-2 
cells by M. penetrans has been shown to begin after 2 h of infection [36]. 
The intracellular fate of invading bacteria can vary greatly. Most invasive bacteria appear to 
be able to survive intracellularly for extended periods of time, at least if they have reached a 
suitable host cell [37]. Other engulfed bacteria are degraded intracellularly via phagosome-
lysosome fusion. The invasive bacteria either remain and multiply within the endosomes 
after invasion or are released via exocytosis and/or the lysis of the endosomes which may 
allow multiplication within the cytoplasm. Most ultrastructural studies performed with 
engulfed mycoplasmas revealed mycoplasmas within membrane-bound vesicles [30, 33, 38]. 
Persistence of M. penetrans within NIH/3T3 cells, Vero cells, human endothelial cells, HeLa 
cells, WI-38 cells, and HEp-2 cells has been observed over a 48–96 h postinfection [19, 23]. M. 
gallisepticum remains viable within HeLa cells during 24–48 h of intracellular residence [31]. 
The observation of vesicles stuffed with M. penetrans in various host cells was taken as an 
indication that M. penetrans is able to divide within intracellular vesicles of the host cells 
[19]. Nonetheless, the intracellular multiplication of mycoplasmas remains to be 
convincingly demonstrated. 
  
Figure 3. Confocal micrographs demonstrating binding and internalization of M. hyorhinis (green 
fluorescence) by melanoma cells. A, Control of uninfected melanoma cells; B, Formaldehyde fixed 
melanoma cells infected with mycoplasma (bacteria on the melanoma cell surface); C, Native melanoma 
cells infected by mycoplasma (bacteria internalized by cells). 
Almost all invasive bacteria that come into contact with the host cell surface trigger 
cytoskeletal rearrangements that facilitate bacterial internalization [35, 39]. Involvement of 
the host cell cytoskeleton in internalization is considered to be the result of a host cell signal 
transduction cascade induced by the invasive bacterium. As in many signal transduction 
processes initiated by bacteria, kinases and/or phosphatases are usually involved [39]. The 
invading mycoplasmas generate uptake signals that trigger the assembly of highly 
organized cytoskeletal structures in the host cells [23]. Yet, the nature of these signals and 
the mechanisms used to transduce them are not fully understood. Specific activation of 
protein kinases occurs during the internalization of most of the bacteria taken up by 
microtubule-dependent mechanisms [16]. It has been shown that invasion of HeLa cells by 
M. penetrans is associated with tyrosine phosphorylation of a 145-kDa host cell protein [21]. 
Tyrosine phosphorylation activates phospholipase C to generate two second messengers: 
phosphatidylinositol metabolites and diacylglycerol (DAG). Changes in host cell lipid 
turnover occur as a result of M. penetrans binding and/or invasion of Molt-3 lymphocytes 
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[40]. These changes include the accumulation of DAG and the release of unsaturated fatty 
acids, predominantly long-chain polyunsaturated ones such as docosahexanoic acid (C22:6, 
40]. Nonetheless, metabolites of phosphatidylinositol were not detected. These observations 
support the hypothesis that M. penetrans stimulates host phospholipases to cleave 
membrane phospholipids, thereby initiating the signal transduction cascade. Because in 
HeLa cells, which are invaded by M. penetrans, DAG is generated, it is likely that the protein 
kinase C is activated in the host cells. Indeed, transient protein kinase C activation was 
demonstrated in invaded HeLa cells by several methods, including translocation to the 
plasma membrane and enzymatic activity [22]. However, activation was weak and transient, 
peaking at 20 min postinfection. How any of these different signal transduction events lead 
to specific microtubule activity resulting in mycoplasmal internalization is unknown. The 
role of these signals in the penetration, survival, and proliferation of mycoplasmas within 
host cells, as well as the involvement of the lipid intermediates in the pathobiological 
alterations taking place in the host cells, merit further investigation.  
3.3 Fusion with host cells 
The lack of a rigid cell wall allows direct and intimate contact of the mycoplasma membrane 
with the cytoplasmic membrane of the eukaryotic cell. Under appropriate conditions, such 
contact may lead to cell fusion. Fusion of mycoplasmas with eukaryotic host cells has been 
first observed in electron microscopic studies [41]. The development of energy transfer and 
fluorescence methods has enabled investigation of the fusion process on a quantitative basis 
in an experimental cell culture-mycoplasma system and has also allowed the identification 
of fusogenic mycoplasmas. In all the fusogenic Mycoplasma species tested, fusogenicity is 
dependent on the unesterified cholesterol content of the cell membrane [42]. Fusogenic 
activity can be found only among mycoplasmas requiring unesterified cholesterol for 
growth, whereas species, which do not require cholesterol, are nonfusogenic. Among the 
Mycoplasma species, the human mycoplasma, M. fermentans, is highly fusogenic, capable of 
fusing with a variety of cells [2]. It is widely accepted that the reorganization of the 
membrane structure that occurs during fusion requires that the lipid bilayer is broken up 
and that other inverted configurations, such as reversed nonbilayer aggregates, are being 
formed [43, 44, 45]. It has been shown that the polar lipid fraction of M. fermentans is capable 
of enhancing the fusion of small, unilamellar phosphatidylcholine-cholesterol (1:1 molar 
ratio) vesicles with Molt-3 lymphocytes in a dose-dependent manner, suggesting that a lipid 
component acts as a fusogen [17, 46]. In an attempt to identify the fusogen, detailed lipid 
analyses of M. fermentans membranes were performed [17, 47, 48], revealing that the polar 
lipid fraction of this organism contains unusual choline-containing ether 
phosphoglycolipids, 1-O-alkyl/alkenyl-2-O-acyl-glycero-3-phosphocholine and its lyso-form 
1-O-alkyl/alkenyl-glycero-3-phosphocholine [49]. The ether lipids, mainly the lyso-
derivative has a marked effect on the fusion of M. fermentans with host eukaryotic cells [50]. 
Very little is known about the role of membrane proteins in the fusion process. The 
observation that fusion of M. fermentans with Molt-3 cells was inhibited by pretreatment of 
intact M. fermentans with proteolytic enzymes [51] implies that this organism possesses a 
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proteinase-sensitive receptor(s) responsible for binding and/or the establishment of tight 
contact with the cell surface of the host cell involved in fusion. During the fusion process, 
mycoplasma components may be delivered into the host cell and affect the normal functions 
of the cell. A whole array of hydrolytic enzymes has been identified in mycoplasmas [1, 15, 
52]. Most remarkable are the mycoplasmal nucleases [1] that may degrade host cell DNA. It 
has recently been shown that M. fermentans contains a potent phosphoprotein phosphatase 
[52]. The delivery of an active phosphoprotein phosphatase into the eukaryotic cell upon 
fusion may interfere with the normal signal transduction cascade of the host cell.  
4. Effects of mycoplasmas on cell cultures 
Effects on cell function and metabolism have long been recognized as common in 
mycoplasma contaminated cell cultures. The nature of the effects depends on the 
contaminating species and strain of mycoplasma, and on the type of cell infected. 
Frequently, the effects are due to nutrient deprivation, such as the depletion of amino acids, 
sugars, fatty acids, cholesterol or nucleic-acid precursors [5], the depletion of choline [4] or 
the activity of mycoplasmal endonucleases [53], mycoplasmal arginine deiminase [54] or 
mycoplasmal thymidine phosphorylase [55]. Some mycoplasmas have been shown to 
produce severe cytopathic effects (CPE) characterized by stunted, abnormal growth and 
rounded, degenerated cells, apparently due to the promotion or inhibition of apoptosis [56]. 
The promotion of apoptosis may be due to direct effects of mycoplasma components. Thus, 
M. bovis infection sensitizes some host cells to apoptosis through participation of 
mycoplasmal endonucleases [53]. Choline deficiency induced by M. fermentans enhances rat 
astrocyte apoptosis [4]. Some mycoplasmas promote host cell death via induction of pro-
apoptotic genes [57, 58]. Pro-apoptotic and anti-apoptotic mycoplasmas appear to alter 
apoptosis regulatory genes differently [59].  
4.1. Competition for precursors 
Genomic analyses of mycoplasmas have revealed the limited biosynthetic capabilities of 
these microorganisms [60, 61]. Mycoplasmas apparently lost almost all the genes involved in 
the biosynthesis of amino acids, fatty acids, cofactors, and vitamins and therefore depend on 
the host microenvironment to supply the full spectrum of biochemical precursors required 
for the biosynthesis of macromolecules [1]. Competition for these biosynthetic precursors by 
mycoplasmas may disrupt host cell integrity and alter host cell function. Nonfermenting 
Mycoplasma spp. utilize the arginine dihydrolase pathway for generating ATP [62] and 
rapidly deplete the host's arginine reserves affecting protein synthesis, growth and host cell 
divisions. The effect on the cellular genome may be expressed in chromosomal breakage, 
multiple translocation events, reduction in chromosome number and the appearance of new 
and/or additional chromosome variants [63]. Since histones are arginine rich, it was 
suggested that mycoplasmas may exert their effects on cellular genomes by depleting 
arginine and thus inhibiting histone synthesis [62]. However, as fermenting mycoplasmas 
also induce chromosomal aberrations, other mechanisms, including competition for nucleic 
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acid precursors, or degradation of host-cell DNA by mycoplasma nucleases, may be 
involved. M. fermentans infection of cell cultures has been shown to result in a choline-
deficient environment and in the induction of apoptosis [64]. Choline is an essential dietary 
component that ensures the structural integrity and signaling functions of the cell 
membranes; it is the major source of methyl groups in the diet, and it directly affects lipid 
transport and metabolism and the cholinergic neurotransmission and transmembrane 
signaling of cells of the nervous system [65].  
4.2. Cytopathic effects 
Mycoplasmal attachment to eukaryotic cells may sometimes lead to a pronounced 
cytopathic effect. Attachment permits the mycoplasma contaminant to release noxious 
enzymatic and cytolytic metabolites directly onto the tissue cell membrane. Some 
mycoplasmas selectively colonize defined areas of the cell culture. This results in 
microcolony formation producing microlesions and small foci of necrosis, e.g., M. pulmonis, 
or form plaques, e.g., M. gallisepticum, in an agar overlay system [5]. Microcolonization 
suggests that mycoplasma-specific receptors are localized in defined areas of the cell 
monolayer. However, other fermenting mycoplasmas, e.g., M. hyorhinis, attach to every cell 
and destroy the entire monolayer, producing a generalized cytopathic effect. With HeLa 
cells infected by the invasive M. penetrans, the most pronounced effect was the vacuolation 
of the host cells [22]. The vacuoles appeared to be empty, differing from the described 
membrane-bound vesicles containing clusters of bacteria [19]. The number and size of the 
vacuoles depended on duration of infection. Because vacuolation is not obtained with M. 
penetrans cell fractions [22], it is unlikely that a necrotizing cytotoxin is involved in the 
generation of the cellular lesions. A possible mechanism that leads to vacuolation may be 
associated with the accumulation of organic peroxides upon invasion of HeLa cells by M. 
penetrans. Indeed, when HeLa cells were grown with the antioxidant α-tocopherol, the level 
of accumulated organic peroxides was extremely low, and vacuolation was almost 
completely abolished [22].  
Being unable to synthesize nucleotides, mycoplasmas developed potent nucleases, either 
soluble ones secreted into the extracellular medium or membrane-bound nucleases [1, 66, 
67] apparently as a means of producing nucleic acid precursors required for metabolism. It 
has been shown that, occasionally, secreted mycoplasmal nucleases are taken up by the host 
cells [68]. Thus, it was suggested that the cytotoxicity of M. penetrans is mediated at least in 
part by a secreted mycoplasmal endonuclease that is cleaving DNA and/or RNA of the host 
cells [66], and the endonuclease activity of M. bovis was implicated in the increased 
sensitivity of lymphocytic cell lines to various inducers of apoptosis [69].  
4.3. Transformation of cells mediated by mycoplasmas 
Cell culture contamination may go undetected because mycoplasma infections do not 
produce the overt turbid growth that is commonly associated with bacterial and fungal 
contamination. Mycoplasma growth can grow in close interaction with mammalian cells, 
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often silently for a long period of time. However, prolonged interactions with mycoplasmas 
with seemingly low virulence could, through a gradual and progressive course, induce 
chromosomal instability as well as malignant transformation, promoting tumorous growth 
of mammalian cells [70, 71]. Mycoplasmal-induced malignant transformation is a multistage 
process [70] associated with increased or decreased expression of many genes, especially 
cancer-related genes [72]. Over expression of H-ras and c-myc oncogenes were found to be 
closely associated with both the initial reversible and the subsequent irreversible states of 
the mycoplasma-mediated transformation of cells [71]. In some cases, mycoplasmas have 
been shown to induce the production of proteins that play essential roles in the 
development of malignancy. Examples are the mycoplasmal-promoted production in 
diverse types of cultured cells of bone morphogenetic protein 2 (BMP2) that enhances tumor 
growth by increasing cell proliferation [73]; mycoplasma-induced diminished activation of 
the tumor suppression protein p53, and enhanced fibroblast transformation by the 
oncogenic H-ras [74] ; promotion of cancer cell motility and migration by P37, the major 
immunogen of M. hyorhinis, through activation of the matrix metalloproteinase-2 [75]. 
4.4. Modulation of immune and non-immune cell metabolism 
The effects of mycoplasmas on the immune system are well established and include effects 
on differentiation and activation of innate immunity cells (macrophages, dentritic cells, 
neutrophils, NK) and on adaptive immunity cells (T and B cells). Mycoplasma and 
mycoplasmal components are potent macrophage activators, and stimulate the release of 
various proinflammatory cytokines, such as tumor necrosis factor α (TNFα), interleukin-
1(IL-1), IL-6, NO [4, 76]. In turn, some cytokines participate in lymphocyte differentiation 
and maturation [4]. M. fermentans induces a partial differentiation of the human monocytic 
cell line THP-1 [77]. Mycoplasma-contaminated exosome fractions of dentritic cells are 
mitogens for naive B lymphocytes and promote immunoglobulin secretion [78].  
Mycoplasmas and mycoplasmal components interact with diverse non-immune cells [56, 57, 
58, 79], with some information available on the cellular proteins affected by them. M. 
salivarium and M. fermentans induce the cell surface expression of intercellular adhesion 
molecule 1 (ICAM-1) in human gingival fibroblasts [80]. Hyperammonia toxicity in 
irradiated hepatoma cells has been shown to be due to contamination by mycoplasma 
containing arginine deiminase, that converts arginine to citrulline and ammonia [54]. M. 
pneumoniae induces the expression of the major airway protein mucin (MUC5AC) in 
cultured airway epithelial cells isolated from asthmatic subjects, but not in cells isolated 
from normal subjects; the preferential expression of MUC5AC in cells isolated from 
asthmatic subjects suggests that asthmatic epithelial cells may be primed to respond to the 
mycoplasma [81], thus pointing to the importance of identifying consequences of 
mycoplasma contamination that may be observed only in certain specific types of cultured 
cells. Catabolic mycoplasmal enzymes may interfere with chemotherapy. This is illustrated 
by the finding that the antiviral and cytostatic activity of pyrimidine nucleoside analogues 
(used as chemotherapeutic agents) is markedly decreased in M. hyorhinis contaminated cells, 
due to the mycoplasmal thymidine phosphorylase that degrades pyrimidine nucleoside 
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analogues [55]. Contamination of human cultured neuroblastoma SH-SY5Y and melanoma 
cell lines by M. hyorhinis results in increased levels of calpastatin (the endogenous inhibitor 
of the ubiquitous Ca2+-dependent protease calpain). The calpastatin upregulation resides in 
the M. hyorhinis lipoprotein fraction (LPP), via the IκB/NF-κB transcription pathway [79]. 
LPPs of several other mycoplasma species have also been found to upregulate calpastatin 
[J.D. Kornspan, T. vaisid, S. Rottem and N.S. Kosower, unpublished data]. Amyloid-β-
peptide and Ca2+ (these are central to the pathogenesis of Alzheimer’s Disease) activate 
calpain and are toxic to neuroblastoma cultured cells. The increased calpastatin levels in the 
mycoplasma-infected cells attenuate the calpain-related amyloid-β-peptide and Ca2+-
toxicity. Calpain and calpastatin are widely distributed in biological systems, with the ratio 
of calpastatin to calpain varying among cells. The calpain-calpastatin system has been 
implicated in a variety of cellular physiological and pathological processes [82]. Since 
calpastatin level is important in the control of calpain activity, mycoplasmas may play a role 
in a variety of metabolic and signal transduction pathways in some types of cultured cells. 
The mycoplasma-induced elevation of calpastatin provides an example of mycoplasmal 
effects on intracellular proteins in non-immune cells, resulting in important alterations in 
the host cell functions. 
4.5. Effect on virus infection  
Mycoplasmas may alter the progress of viral infections in cell cultures [83, 84]. As 
mycoplasmas may also cause virus-like CPE, many investigators have mistaken cytolytic 
mycoplasmas for viruses. Like viruses, mycoplasmas are filterable, hemadsorbant, 
hemagglutinant, resistant to certain antibiotics, able to induce chromosomal aberrations, and 
sensitive to detergents, ether and chloroform; thus the first established mycoplasma 
pathogens of humans (M. pneumoniae), animals (M. mycoides) or plants (Spiroplasma spp.) 
were believed to be viruses. Some mycoplasmas have no detectable effect on viral growth. 
Others can decrease, or even increase, virus yields in infected cell culture [85]. The effect 
depends on the strain or species of mycoplasma, the virus, and the cell culture used. At least 
two mechanisms responsible for decreasing viral yields in vitro have been identified. The 
cytolytic, fermenting mycoplasmas suppress metabolism and growth, resulting in a decrease 
in viral yields. Arginine-utilizing mycoplasmas decrease the titers of arginine-requiring 
DNA viruses by depleting arginine from the medium [62]. Mycoplasmas may render cell 
cultures less sensitive to exogenously supplied interferon and thus to increase virus yields 
[86]. Mycoplasmas may also inhibit viral transformation of cell cultures by known oncogenic 
viruses [5, 87]. 
4.6. Signal transduction pathways 
Mycoplasmas and mycoplasmal membrane LPPs attach to certain Toll-like receptors (TLRs) 
of the host cell membrane. The main TLR involved appears to be TLR2, with participation of 
TLR6 as coreceptor. In some cases, TLR1 is also involved [88]. The interaction with the 
receptors triggers cascades of cellular signals within the cell, and the complex pathways 
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culminate in a variety of host cell responses. Mycoplasmas and mycoplasmal LPP are 
known to activate the transcription factors NF-ߢB [74, 79] and AP-1 [1 4], via TLR- 
downstream cascades involving kinases (MAPKKKs-IKKs and MAPKKKs-MAPKKs- 
MAPKs). Known mycoplasma-affected target genes are mainly those responsible for 
proinflammatory proteins [4], and those involved in malignant cell transformation [72], with 
little information available on genes responsible for other proteins [53, 79, 80, 81]. 
5. Detecting mycoplasmas in cell cultures  
The ubiquitous nature of mycoplasma in man, animals and the environment increases the 
likelihood of the introduction of these organisms into cell cultures or a manufacturing 
process. Currently, the recommended test requirements for biologics are as follows: (1) The 
master- and working cell seed banks must be free of mycoplasmas. (2) The product-harvest 
concentrates must be free of mycoplasmas. (3) All products produced in cell cultures, a 
generic term used for all tissue cells grown in vitro, must be tested. This includes viral 
vaccines (such as poliovirus, adenovirus, measles, rubella, mumps and rabies), monoclonal 
antibodies, immunological modifiers and cell-culture-derived blood products, such as 
tissue-type plasminogen and erythropoietin. Guidelines for mycoplasma testing of cell 
cultures and biologics is addressed in several international pharmacopoeias e.g., United 
States Pharmacopoeia, (USP 33/NF 28 <63>and <1226>, Mycoplasma tests, 2010); European 
Pharmacopoeia (EP 2.6.7., Mycoplasmas, 7th ed.; 2012); Japanese Pharmacopoeia (JP); 
Section 21 of the Code of Federal Regulations (CFR), International Conference on 
Harmonisation (ICH), and FDA- Points to Consider (PTC) documents. Several different 
approaches are being used to detect mycoplasmas in contaminated tissue cultures including 
the culture procedures, a variety of nonspecific procedures and the polymerase chain 
reactions (PCR). 
5.1. Standard culture procedures 
The culture procedures require that the tested material will be inoculated onto solid and 
liquid growth media capable of growing a variety of mycoplasma including aerobic, 
microaerophilic and anaerobic strains. Broth cultures are incubated and sub passaged to 
plate agar. After the required incubation period, the agar plates are observed 
microscopically for the presence of mycoplasma colonies [5]. The variation inherent in the 
complex media usually used for in vitro culture of mycoplasmas is due to batch variation in 
compounds such as sera, or yeast extract. Such variation makes the development of defined 
media attractive. However, a key problem has been the supply of lipids in an available, but 
non-toxic form, hence, defined artificial media have been developed for only a few species 
[1]. Most mycoplasmas produce microscopic (100 - 400 µm in diameter) colonies with a 
characteristic 'fried-egg' appearance, growing embedded in the agar, although some (e.g. M. 
pulmonis) may not grow completely embedded, and some freshly-isolated pathogens (e.g. 
M. pneumoniae) produce a more granular, diffuse colony-type. Since they usually grow 
embedded, mycoplasma colonies can be distinguished from other bacteria by: (1) specific 
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colony shape; (2) being difficult to scrape from the agar surface. Mycoplasmas growing on 
agar can be identified more specifically by immunofluorescent procedures, using 
fluorophores conjugated to species-specific antibodies [4]. The traditional culture-based 
techniques are relatively sensitive, capable of detecting as few as 1-10 colony forming units 
of mycoplasmas and therefore are required by pharmacopoeias and regulatory authorities 
worldwide. Nonetheless, this procedure is time consuming requiring a minimum of 28 days 
to complete, costly and not sensitive to non-cultivable strains, therefore, the development of 
more accurate and faster techniques are needed to facilitate faster detection of a 
contaminating mycoplasma and more rapid corrective action. 
5.2. Polymerase chain reaction (PCR) 
PCR methodology has existed for decades, however conventional PCR and real-time PCR 
assays have only recently been considered for mycoplasma detection in cell cultures and 
biological products. These assays are often based on the amplification of conserved regions of 
the 16S rDNA [89, 90] or the spacer region between the 16S and 23S rDNA [91, 92]. The PCR 
approach is rapid (1-2 days), inexpensive, and independent of culture conditions. Specific 
oligonucleotide primers capable of amplifying the conserved regions and thus detecting DNA 
of multiple Mollicutes species while excluding other contaminating DNA are used in the PCR 
assays. In comparison to conventional PCR methods, real-time PCR assays are quicker, 
simpler, and more suitable for handling a large number of samples [93]. Nonetheless, some of 
the primers used are not entirely specific for Mollicutes [94, 95]. Thus, sequence homologies 
between Mollicutes spp. and Chlamydia spp. led to false-positive results in Chlamydial cell 
cultures tested for mycoplasma contamination with a commercial PCR kit [96].  
Throughout the last decade, new PCR assays for mycoplasma detection, which appeared to 
resolve these issues, were described, while being sufficiently simple and inexpensive for 
routine use. For example, a PCR assay which applied readily available techniques in DNA 
extraction together with a modified single-step PCR using a primer pair that was 
homologous to a broad spectrum of mycoplasma species was proposed [97]. A high 
sensitivity and specificity for mycoplasma detection in cell production cultures was made 
possible through the combination of three key techniques: 8-methoxypsoralen and UV light 
treatment to decontaminate PCR reagents of DNA; hot-start Taq DNA polymerase to reduce 
nonspecific priming events; and touchdown PCR to increase sensitivity while also reducing 
nonspecific priming events. Another proposed PCR assay for mycoplasma detection was a 
sensitive two-stage PCR procedure which detected 13 common mycoplasmal contaminants 
[92]. For primary amplification, the DNA regions encompassing the 16S and 23S rRNA 
genes of 13 species were targeted using general mycoplasma primers. The primary PCR 
products were then subjected to secondary nested PCR, using two different primer pair sets, 
designed via the multiple sequence alignment of nucleotide sequences obtained from the 13 
mycoplasmal species. The nested PCR, which generated DNA fragments of 165-353 bp, was 
found to be able to detect 1-2 copies of the target DNA, and evidenced no cross-reactivity 
with the genomic DNA of related microorganisms or of human cell lines, thereby 
confirming the sensitivity and specificity of the primers used.  
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Other studies showed that reverse transcription-PCR (RT-PCR) methods based on detection 
of the 16S rRNA, which is present in multiple (103–104) copies per bacterial cell [98, 99], are 
more sensitive than PCR detecting the 16S rDNA. Thus, a direct side-by-side comparison of 
RT-PCR and PCR targeting the 16S rRNA and the 16S rRNA gene, respectively, 
demonstrated that RT-PCR was able to provide up to a two-logarithm higher sensitivity of 
bacteria detection in comparison with the PCR-based assay [90, 100] and the sensitivity 
provided by RT-PCR is approaching the sensitivity of conventional microbiological culture 
methods [100]. Therefore, it was suggested that RT-PCR methods targeting the bacterial 16S 
or 23S rRNAs are having the real potential to provide the sensitivity of mycoplasma 
detection close to or even higher than that of conventional culture methods [101] .  
Recently, the MycoTOOL PCR test kit from Roche (Roche, Diagnostic GmbH, Penzberg, 
Germany) was approved by the European Medicines Agency (EMEA) for release testing of 
pharmaceutical products. It is the first commercially available Mycoplasma PCR test that 
can replace traditional Mycoplasma tests (culture method as well as indicator cell culture 
method) during pharmaceutical production. In June 2009 the FDA approved the PCR 
concept of this test for seven commercial products from Genentech. Earlier, Bayer Health 
Care received approval for a pharmaceutical product from the EMEA and Japan’s Ministry 
of Health, Labour and Welfare (MHLW) using the same PCR-based test concept. Guidelines 
describing acceptable protocols for specific PCR methods are provided by the EP and JP. 
The pharmacopoeias, PTC, and CFR protocols vary with their recommendations on how to 
conduct the PCR assays. 
5.3. Indirect non-specific procedures 
Some 'non-cultivable' mycoplasma strains cannot readily be grown on standard agar or 
broth-culture media [5], and cell-assisted culture is required for their isolation. Cell-culture 
systems are therefore a valuable ancillary tool for the isolation and detection of 
mycoplasmas and 'indicator cell culture' procedures using either VERO (African green 
monkey kidney), or NIH 3T3 cell cultures have been developed [102]. These cell lines are 
susceptible to infection by the majority of mycoplasmas and are therefore a reliable 
'indicator' system for detecting mycoplasma infection. These approaches are particularly 
useful for the identification and detection of mycoplasmas that adhere to host-cell surfaces. 
The indirect non-specific procedures require that the tested material will be inoculated 
directly onto tissue culture cover slips or flasks containing a monolayer of the indicator  
cells. The indicator cell culture inoculated with the tested material are than fixed and stained 
with DNA-binding fluorochromes using bisbenzimidazole (such as Hoechst or DAPI  
stains) [103].  
Identification of contaminating mycoplasma is by visual observation via fluorescent 
microscopy. Mycoplasmas are detected by their characteristic particulate or filamentous 
pattern of bright fluorescence on the cell surface (Figure 4) and, if contamination is heavy, in 
surrounding areas. These procedures are suitable for use with either non-specific DNA 
stains for detecting mycoplasmas, or in conjunction with mycoplasma-speciation methods, 
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such as by immunofluorescence procedures using species-specific polyclonal antisera, or 
monoclonal antibodies, conjugated with fluorescein or peroxidase [104]. A wide variety of 
luminol-dependent chemiluminescence and bioluminescent methods were described [5, 63].  
 
Figure 4. Mycoplasma contaminated eukaryotic cells stained with a fluorescent DNA stain. 
Biochemical identification methods have also been in use [5, 78]. Procedures based on the 
comparative utilization of uridine versus uracil in contaminated versus mycoplasma-free 
cell cultures have been suggested [105]. Other methods are based on the detection of 
enzyme activity present in mycoplasmas, but absent, or minimal in uninfected cell cultures. 
The enzymic activities measured include: arginine deiminase [62]; thymidine, uridine, 
adenosine or pyrimidine nucleoside phosphorylase [102]; hypoxanthine or uracil 
phosphoribosyl transferase activities [106]. Positive results are based on arbitrary values, 
making low levels of mycoplasma contamination difficult to detect. Detection kit that 
provide a new, sensitive and rapid biochemical method was recently presented (Cambrex, 
Bio Science, Caravaggio, Bergamo, Italy). The test is based on a bioluminescent assay which 
can be assessed within 20 min for daily determination of the mycoplasma status of cell 
cultures. The performance sensitivity and specificity of the kit was evaluated and compared 
to the PCR/ELISA detection kit (Roche, Diagnostic GmbH, Penzberg, Germany) and the 
standard culture method [5]. Recently, a simple and inexpensive assay monitoring 
mycoplasma contamination, based on degradation of the Gaussia luciferase reporter in cell 
cultures was described [107]. This assay has been shown to be more sensitive for detecting 
mycoplasma contamination in seven different cell lines as compared to a commercially 
available bioluminescent assay [107]  
6. Eliminating mycoplasmas from infected cultures 
Ever since mycoplasma contamination of cell cultures was first reported, attempts have been 
made to develop methods for the elimination of mycoplasmas, including the use of antibiotics 
such as tetracycline, kanamycin, novobiocin, tylosin, gentamycin, doxycycline, thiayline and 
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quinolones; surface-active agents; anti-mycoplasma antisera and prolonged heating treatments 
(40-42 °C) [63, 108]. Eliminating mycoplasmas by passage of a cell culture through nude mice 
[109] has been successful for some, but not all, mycoplasmas. An efficient procedure for 
eliminating mycoplasmas is based on the selective incorporation of 5-bromouracil (5-BrUra) 
into mycoplasmas, and the induction of breaks by light in the 5-BrUra-containing DNA [110]. 
The unusually high content of A+T makes the mycoplasma DNA an excellent candidate for the 
induction of breakage by the combined action of 5-BrUra, 33258-Hoechst and visible light 
[110]. Some of the elimination procedures may apply to some, but not all, mycoplasma species; 
some of them are laborious and/or time consuming. It was suggested, therefore, that whenever 
possible, the infected cell culture should be discarded and replaced with a mycoplasma-free 
culture [108]. When the cell culture is irreplaceable, the use of antibiotic mixtures, are the 
commonest approaches. One has to keep in mind that cell-culture contaminants that have been 
continuously exposed to antibiotics develop resistance to the drug, and antibiotic-resistant 
strains have been isolated for most Mycoplasma species tested. Treatment may also induce the 
selection of a subpopulation of cells and the treated cell culture may differ in its characteristics 
from the original culture.  
Among the antibiotics that were shown to have strong anti-mycoplasma properties are 
different inhibitors of protein synthesis mainly tetracyclines or macrolides as well as 
quinolones [111]. The target enzymes of quinolones are considered to be DNA gyrase and 
topoisomerase IV which are essential enzymes for controlling the topological state of DNA 
in DNA replication and transcription . Most recently the quinolone garenoxacin was found 
to be a most valuable quinolone in the elimination M. pneumoniae [112].  
The addition of antibiotics to the culture medium during a limited period of time (1-3 wk) is 
a simple, inexpensive, and very practical approach for decontaminating continuous cell 
lines. BM-cyclin (trade name of Roche, Mannheim, Germany), a combination of tiamulin 
and minocycline (both inhibiting protein synthesis), was introduced by Jung et al. [113] who 
show that three cycles of treatment of a contaminated cell culture with BM-cyclin I 
(containing the macrolide tiamulin) at a final concentration of 10 µg/ml for 3 days followed 
by BM-cyclin II (containing the tetracycline minocycline) at a concentration of 5 µg/ml for 4 
days completely eradicated mycoplasmal infection from cultured cells [113]. 
Uphoff and Drexler [111, 114] examined the effectiveness of several quinolones and BM-
cycline protocols. The contaminated cell cultures were exposed to one of the following five 
antibiotic regimens: mycoplasma removal agent (MRA, quinolone; a 1-wk treatment), 
enrofloxacin (quinolone; 1 wk), sparfloxacin (quinolone; 1 wk), ciprofloxacin (quinolone; 2 
wk), and BM-Cyclin (alternating tiamulin and minocycline; 3 wk). The mycoplasma 
infection was permanently eliminated by the various antibiotics in 66-85% of the cultures 
treated. Mycoplasma resistance was seen in 7-21%, and loss of the culture as a result of 
cytotoxically caused cell death occurred in 3-11% of the cultures treated [111, 114].  
Recently, MycoZap (trade name of Lonza, Verviers, Belgium) treatment has been introduced 
as a new therapeutic tool able to overcome the eukaryotic cytotoxicity of fluoroquinolones 
and BM-Cyclins [115]. MycoZap kit (Lonza, Verviers, Belgium) includes a combination of 
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patented antibiotic and antimetabolic agents. An evaluation of the MycoZap kit 
performance was recently presented by Mariotti et al., [116] who exposed mycoplasma 
contaminated cells to the MycoZap protocol and compared the results obtained to the 
eradication efficiency of enrofloxacin (Fluka, Bio-Chemika, Missouri, USA), MRA 
(Euroclone, Lugano, Switzerland), ciprofloxacin and the BM-Cyclin protocol. Treatment of 
contaminated cell cultures by MycoZap, MRA, ciprofloxacin, enrofloxacin and BM-cycline, 
eliminated mycoplasma infection by 46%, 29%, 43%, 40% and 57% respectively. The use of 
an eradication mixture based on a combination of the antibiotics BM-Cyclins, ciprofloxacin, 
enrofloxacin and MRA was able to clean 88.6% of the infected cultures, whereas the addition 
of MycoZap to the eradication mixture resulted in the eradication of mycoplasmas from 
100% of the contaminated cell cultures [116]. 
7. Conclusions 
Mycoplasmas are shown to cause various alterations in cultured cells. As described above, 
some alterations are due to direct effects on the cells by mycoplasma components, and other 
alterations are due to indirect effects, via inducing the host cell to alter its gene and protein 
expression and activity. It is important to emphasize the fact that mycoplasmal-altered cell 
phenotype and function is often observed in specific types of cells under special conditions, 
e.g., when the cultured cells are exposed to certain agents. The detection of mycoplasma 
contamination, and the identification of the factors and pathways involved in the 
mycoplasmal effects are thus of utmost importance in handling cultured cells, including 
using stem cells for differentiation to specific tissues. 
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